Aslan Aygun - Istanbul University | 人才画像

基本信息

Career Trajectory

Bio

Aslan Aygun currently works at the Istanbul University - Cerrahpasa, Cerrahpasa Faculty of Medicine Department of Nuclear Medicine. Aslan does research in Pharmacology, Nuclear Chemistry and Plastic Surgery. Their current project is 'ga-68 labelling'.

Research Interests

Papers共 13 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

177Lu-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule

Sait Sager,Aslan Aygun,Emre Karayel,Huseyin Pehlivanoglu,Kerim Sonmezoglu

Journal of nuclear medicine technology（2019）

Cited0Views0WOSBibtex

Comparison of Ga-68 PSMA Positron Emission Tomography/computerized Tomography with Tc-99m MDP Bone Scan in Prostate Cancer Patients

Lebriz Uslu-Besli,Sait Sager,Elife Akgun,Sertac Asa,Onur Erdem Sahin,Cetin Demirdag,Ekrem Guner,Baresh Razavi Khosroshahi,Emre Karayel, Huseyin Phelivanoglu,Asian Aygun,Ilhami Uslu,Zubeyr Talat,Kerim Sonmezoglu

Turkish journal of medical sciences（2019）

Cited11Views0WOSBibtex

SPECT Radyofarmasötikleri İşaretleme Yöntemleri Ve Radyasyon Korunması

Aslan Aygün,Emre Karayel,Hüseyin Pehlivanoğlu,Meltem Ocak

Turkiye Klinikleri Nuclear Medicine - Special Topicsno. 3 (2019): 56-65

Cited0Views0Bibtex

Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

Levent Kabasakal,Turkay Toklu,Nami Yeyin,Emre Demirci,Mohammad Abuqbeitah,Meltem Ocak,Aslan Aygun,Emre Karayel,Huseyin Pehlivanoglu,Nalan Alan Selcuk

Molecular imaging and radionuclide therapy（2017）

Cited56Views0WOSBibtex

The Role of Psma Pet/Ct Imaging in Restaging of Prostate Cancer Patients with Low Prostate-Specific Antigen Levels

Levent Kabasakal,Emre Demirci,Jamal Nematyazar,Resit Akyel, Baresh Razavi,Meltem Ocak,Aslan Aygun,Can Obek,Ali R. Kural

Nuclear medicine communicationsno. 2 (2017): 149-155

Cited36Views0WOSBibtex

Pre-therapeutic dosimetry of normal organs and tissues of 177 Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Levent Kabasakal,Mohammad AbuQbeitah,Aslan Aygün,Nami Yeyin,Meltem Ocak,Emre Demirci,Turkay Toklu

European journal of nuclear medicine and molecular imaging（2015）

Cited173Views0WOSBibtex

173

Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

Levent Kabasakal,Emre Demirci,Meltem Ocak,Reşit Akyel,Jamal Nematyazar,Aslan Aygun,Metin Halac,Zubeyir Talat,Ahmet Araman

NUCLEAR MEDICINE COMMUNICATIONS（2015）

Cited144Views0WOSBibtex

144

Evaluation and Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT Imaging in Well-Differentiated Thyroid Cancer

Meltem Ocak,Emre Demirci,Levent Kabasakal,Aslan Aygun,Rumeysa O. Tutar,Ahmet Araman,Bedii Kanmaz

Nuclear medicine communications（2013）

Cited25Views0WOSBibtex

Radiation absorbed dose calculation of Lu-177-DOTA-TATE therapy in patients with somatostatin receptor expressing tumors

Nami Yeyin,Handan Tanyildizi,Emre Demirci,Resit Akyel,Aslan Aygun,Turkay Toklu,Meltem Ocak,Levent Kabasakal,Bedii Kanmaz

mag（2013）

Cited23Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn